期刊文献+

Balb/C小鼠免疫重组蓖麻毒素与相思子毒素B链嵌合体蛋白的免疫应答

Immune response to a recombinant B chain chimeric protein of ricin and abrin in Balb/C mice
原文传递
导出
摘要 【目的】探讨重组蓖麻毒素、相思子毒素B链蛋白(RTB-ATB)免疫Balb/C小鼠的免疫机制。【方法】雌性Balb/C小鼠随机分为两组:RTB-ATB组和PBS组,分别腹腔免疫4次,间隔1周;间接ELISA检测血清中IgG效价和抗体分型,流式细胞技术检测细胞因子IFN-γ、IL-4,并进行攻毒实验和体外中和实验。【结果】四免后RTB-ATB组血清IgG、IgG1的效价与PBS对照组差别有统计学意义(P<0.05),而IgG2a未发生明显变化;IL-4的表达量RTB-ATB组与PBS组相比差别有显著性(P<0.05),而IFN-γ未发生变化(P>0.05)。攻毒保护实验和体外中和实验结果说明,嵌合体蛋白RTB-ATB可以抵抗4×LD50的天然AT或RT攻毒。【结论】RTB-ATB诱导以IgG1为主的抗体和Th2优势应答且显示出良好的免疫原性,为二价疫苗的研制奠定基础。 【Objective】To explore the immune mechanism of a recombinant B chain chimeric protein of ricin and abrin(RTB-ATB) in Balb/C mice.【Methods】The female Balb/C mice were randomly divided into two groups:RTB-ATB group and PBS group.The mice were treated with intraperitoneal(i.p.) immunization four times and an interval of one week.Ig titer and antibody typing in serum were detected by indirect ELISA.IFN-γ and IL-4 were detected by flow cytometry.Then the protein neutralization assay and efficacy of passive protection were done.【Results】Obvious difference in the serum titer of IgG and IgG1 was found between RTB-ATB group and PBS group(P〈0.05),while there was no change in IgG2 a.Significant difference in the expression of IL-4 was also observed between two groups(P〈0.05),while there was no change in IFN-γ(P〈0.05).Meanwhile,all Balb/C mice survived after challenged with 4×LD50 of RT or AT in the tests of native toxin challenge and passive protection.【Conclusion】RTB-ATB can induce IgG1-based antibodies and Th2 dominant immune response.It shows good immunogenicity,which provides a foundation for the development of bivalent vaccine.
出处 《武警后勤学院学报(医学版)》 CAS 2017年第11期925-928,共4页 Journal of Logistics University of PAP(Medical Sciences)
基金 武警后勤学院开放基金项目(WHKF201503) 武警后勤学院"2110"专项课题
关键词 蓖麻毒素 相思子毒素 B链 免疫应答 生物恐怖 Ricin Abrin B chain Immune response Bioterrorism
  • 相关文献

参考文献1

二级参考文献16

  • 1Han YH, Gao S, Xin WW, et al. A recombinant mutant abrin A chain expressed in Escherichia coli can be used as an effective vaccine candidate[J]. Hum Vaccin, 2011, 7(8): 838-844.
  • 2Balali Mood M, Moshiri M, Etemad L. Medical aspects of bio-terrorism[J]. Toxicon, 2013, 69:131-142.
  • 3Surendranath K, Karande AA. A neutralizing antibody to the a chain of abrin inhibits abrin toxicity both in vitro and in vivo[J]. Clin Vaccine Immunol, 2008, 15(5): 737-743.
  • 4Wang JH, Gao S, Xin WW, et al. A movel recombinant vaccine protecting mice against abrin intoxication[J]. Hum Vaccine Immunother, 2015, 11(3): 1-7.
  • 5Griffiths GD, Lindsay CD, Allenby AC, et al. Protection against inhalation toxicity of ricin and abrin by immunisation[J]. Hum Exp Toxicol, 1995, 14(2): 155-164.
  • 6Smallshaw JE, Ghetie V, Rizo J, et al. Genetic engineering of an immunotoxin to eliminate pulmonary vascular leak in mice[J]. Nat Biotechnol, 2003, 21(4): 387-391.
  • 7Lemley PV, Wright DC. Mice are actively immunized afterpassive monoclonal antibody prophylaxis and ricin toxin challenge[J]. Immunology, 1992, 76(3): 511-513.
  • 8MeGuinness CR, Mantis NJ. Characterization of a novel high-affinity monoclonal immunoglobulin g antibody against the riein B subunit[J]. Infect Immun, 2006, 74(6): 3463-3470.
  • 9Mantis NJ, McGuinness CR, Sonuyi O, et al. Immunoglobulin A antibodies against riein A and B subunits protect epithelial cells from riein intoxication[J]. Infect Immun, 2006, 74(6): 3455-3462.
  • 10Yermakova A, Mantis NJ. Protective immunity to ricin toxin conferred by antibodies against the toxin' s binding subunit (I/TB) [J]. Vaccine, 2011, 19, 29(45): 7925-7935.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部